19812311000001109: Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)
\UK product\Virtual medicinal product\Bevacizumab 1.25mg/0.05ml solution for injection vials\Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)
\UK product\Virtual therapeutic moiety\Bevacizumab\Bevacizumab 1.25mg/0.05ml solution for injection vials\Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)

\Medicinal product\Medicinal product categorized by disposition\Product containing angiogenesis inhibitor\Product containing bevacizumab\Bevacizumab\Bevacizumab 1.25mg/0.05ml solution for injection vials\Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing bevacizumab\Bevacizumab\Bevacizumab 1.25mg/0.05ml solution for injection vials\Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing bevacizumab\Bevacizumab\Bevacizumab 1.25mg/0.05ml solution for injection vials\Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Jan 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

66883401000001113 Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

66883501000001112 Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	VMP prescribing status (attribute)	Caution - AMP level prescribing advised	true	Inferred relationship	Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction special	true	Inferred relationship	Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	Is a	Bevacizumab 1.25mg/0.05ml solution for injection vials	true	Inferred relationship	Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	Has active ingredient	Bevacizumab	true	Inferred relationship	Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	VMP prescribing status (attribute)	VMP valid as a prescribable product	false	Inferred relationship	Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	Has specific active ingredient	Bevacizumab	true	Inferred relationship	Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	Has dispensed dose form	Conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	Has manufactured dose form	Conventional release solution for injection	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order) 1 vial	Has AMP	True	Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
66883401000001113	Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
66883501000001112	Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module